Flexion Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 31 U.S.-traded ETFs. FLXN has around 4.1M shares in the U.S. ETF market. The largest ETF holder of FLXN is the SPDR S&P Biotech ETF (XBI), with approximately 1.66M shares. Investors may also find of interest that the ETF with the largest allocation to FLXN stock is First Trust Nasdaq Pharmaceuticals ETF (FTXH), with a portfolio weight of 1.66%. On average, U.S. ETFs allocate 0.13% of FLXN to their portfolios.
Additionally, FLXN is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with FLXN as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 39.80%.